| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/03/2013 | WO2013146741A1 Tissue staining method |
| 10/03/2013 | WO2013146694A1 Method for detection biological substance |
| 10/03/2013 | WO2013146621A1 Method, device, program, and system for evaluating cerebrovascular disorder, and information communications terminal device |
| 10/03/2013 | WO2013146435A1 Agent for preventing or treating giant cell tumor or chondrosarcoma arising in bone/soft tissue |
| 10/03/2013 | WO2013146249A1 Method for measuring isoelectric point, and sensor chip, measurement device, measurement system and program therefor |
| 10/03/2013 | WO2013146186A1 Method for controlling free lime content of clinker |
| 10/03/2013 | WO2013146065A1 Component measuring device |
| 10/03/2013 | WO2013145939A1 Method for detecting target substance, test kit, and detection equipment |
| 10/03/2013 | WO2013145767A1 Detection kit for influenza a virus |
| 10/03/2013 | WO2013145677A1 Method for evaluating inter-coal adhesion |
| 10/03/2013 | WO2013144957A1 Cellular markers for diagnosis of alzheimer's disease and for alzheimer's disease progression |
| 10/03/2013 | WO2013144743A1 Device and method for dried fluid spot analysis |
| 10/03/2013 | WO2013144662A1 Method of intracellular infectious agent detection in sperm cells |
| 10/03/2013 | WO2013144656A1 Active site probes |
| 10/03/2013 | WO2013144616A1 Breast cancer assay |
| 10/03/2013 | WO2013144615A1 Biological reagent |
| 10/03/2013 | WO2013144528A1 Method for controlling a workability parameter of concrete in a mixer |
| 10/03/2013 | WO2013144509A1 Method and installation for measuring the glass distribution in containers |
| 10/03/2013 | WO2013144413A1 Calcium sensors and methods for detecting intracellular free calcium |
| 10/03/2013 | WO2013144409A2 Vectors for identifying hematopoietic lineage |
| 10/03/2013 | WO2013144374A1 Biorelevant compositions |
| 10/03/2013 | WO2013144344A2 Biomarkers for hpv infections, related diagnostic methods and kits |
| 10/03/2013 | WO2013144325A1 Fatty acid elongation enzymes as targets for cancer diagnostics and therapeutics |
| 10/03/2013 | WO2013143940A1 New lung cancer molecular markers |
| 10/03/2013 | WO2013143873A1 Yarn monitoring method |
| 10/03/2013 | WO2013143839A1 Early biomarkers of age-related low-grade inflammation |
| 10/03/2013 | WO2013143835A1 Infrared spectrometer measurement of droplets collected from an oil mist in a breather pipe of a gas turbine |
| 10/03/2013 | WO2013143756A1 Sample collecting device for droplet and gas sampling in narrow ducts of a gas turbine or any other device with an oil breather |
| 10/03/2013 | WO2013143548A1 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest |
| 10/03/2013 | WO2013143543A1 Insect-based model for testing the effects of nanoparticles on the function and integrity of the blood-brain barrier |
| 10/03/2013 | WO2013143406A1 Sampling and injection device for hematological analyzer |
| 10/03/2013 | WO2013143000A1 Combination therapy for the treatment of cancer |
| 10/03/2013 | WO2013142982A1 Colca1 and colca2 and their use for the treatment and risk assessment of colon cancer |
| 10/03/2013 | WO2013142968A1 Compositions, methods, and plant genes for the improved production of fermentable sugars for biofuel production |
| 10/03/2013 | WO2013142965A1 Sh2 domain variants |
| 10/03/2013 | WO2013142963A1 Methods and devices for multi-dimensional separation, isolation and characterization of circulating tumour cells |
| 10/03/2013 | WO2013142939A1 Methods for predicting and classifying event outcomes |
| 10/03/2013 | WO2013117751A3 Methods related to treatment of inflammatory diseases and disorders |
| 10/03/2013 | WO2013107826A3 Use of cellular biomarkers expression to diagnose sepsis among intensive care patients |
| 10/03/2013 | WO2013104720A3 Use of ccl23 as brain damage marker |
| 10/03/2013 | WO2013101276A3 Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway |
| 10/03/2013 | WO2013096817A3 A testing cartridge comprising electrochemical sensors and an optical microarray |
| 10/03/2013 | WO2013078375A3 Administration of alpha4beta7 hetero-dimer-specific antibody |
| 10/03/2013 | WO2013063398A3 Combined water cut and salinity meter using an array of coaxial probes |
| 10/03/2013 | WO2012097074A3 Systems and methods for single-molecule detection using nanotubes |
| 10/03/2013 | WO2002079425A3 Transgenic mice containing clcn4 chloride ion channel gene disruptions |
| 10/03/2013 | US20130262143 Sample analyzer, sample analyzing method, and sample analyzing system |
| 10/03/2013 | US20130261986 Method for determining lipophilicity |
| 10/03/2013 | US20130261486 Visual Indicating Device for Bad Breath |
| 10/03/2013 | US20130261406 Method for building an algorithm for converting spectral information |
| 10/03/2013 | US20130261176 Method of Detecting Mechanosensing Responses in Bone Cells |
| 10/03/2013 | US20130261167 ANCCA as a Diagnostic Biomarker and Therapeutic Target for Breast Cancers |
| 10/03/2013 | US20130261059 Compositions and Methods for the Diagnosis and Treatment of Primary Insulin-Like Growth Factor Deficiency (PIGFD) and Idiopathic Short Stature (ISS) |
| 10/03/2013 | US20130261045 Green tea polyphenol alpha secretase enhancers and methods of use |
| 10/03/2013 | US20130261025 Methods for detecting inflammatory bowel disease |
| 10/03/2013 | US20130261024 System for Identifying Connections Between Perturbagens and Genes Associated with a Skin Hyperpigmentation Condition |
| 10/03/2013 | US20130261023 Small molecule printing |
| 10/03/2013 | US20130261022 Metabolomic profiling of prostate cancer |
| 10/03/2013 | US20130261021 Microanalysis of cellular function |
| 10/03/2013 | US20130261018 Interferon gene signature and methods of use thereof |
| 10/03/2013 | US20130261016 Diagnostic methods for inflammatory disorders |
| 10/03/2013 | US20130261015 Polypeptide markers for the diagnosis of cancers, and methods for the diagnosis of cancers using the same |
| 10/03/2013 | US20130261013 Compounds and Methods |
| 10/03/2013 | US20130261009 Highly Sensitive Biomarker Panels |
| 10/03/2013 | US20130260481 Analysis device and analysis method |
| 10/03/2013 | US20130260480 Diagnostic methods using bnp |
| 10/03/2013 | US20130260471 Use of cyclic azaboronates as sensitive materials in sensors for detecting the presence of peroxides in a gaseous environment |
| 10/03/2013 | US20130260470 In-Situ Reagent For Detection Of Proteins |
| 10/03/2013 | US20130260413 Analysis result providing system, sample analyzing system, analysis result providing apparatus, sample analysis result providing method, and storage medium |
| 10/03/2013 | US20130260412 Sample processing apparatus, sample analyzer, sample analyzing system, sample processing system and sample processing method |
| 10/03/2013 | US20130260409 Store-operated calcium cellular assay |
| 10/03/2013 | US20130260408 Fatty acid pattern analysis for predicting acute coronary syndrome |
| 10/03/2013 | US20130260406 Methods and materials for monitoring myeloma using quantitative mass spectrometry |
| 10/03/2013 | US20130260402 Anthrax carbohydrates, synthesis and uses thereof |
| 10/03/2013 | US20130260401 Daikenchuto bioassay method and quality management method using same |
| 10/03/2013 | US20130260400 Assay for a type ii collagen biomarker |
| 10/03/2013 | US20130260399 Biomarkers for determining breast cancer bone metastasis |
| 10/03/2013 | US20130260397 Apparatus for sampling of a representative and non-destructive sample of particles from bulk material as well as a method for sampling using the apparatus |
| 10/03/2013 | US20130260395 Method for the diagnosis of and/or monitoring mucormycosis |
| 10/03/2013 | US20130260394 Method for the diagnosis and/or prognosis of inflammatory states |
| 10/03/2013 | US20130260393 Tem-1 diagnostic antibodies |
| 10/03/2013 | US20130260392 Tagged ligands for enrichment of rare analytes from a mixed sample |
| 10/03/2013 | US20130260391 Method Of Determining The Protease Cathepsin B In A Biological Sample |
| 10/03/2013 | US20130260390 Methods and Compositions for Highly Sensitive Detection of Molecules |
| 10/03/2013 | US20130260389 Beta-2 microglobulin as a biomarker for peripheral artery disease |
| 10/03/2013 | US20130260388 Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof |
| 10/03/2013 | US20130260387 Determination of glycated protein |
| 10/03/2013 | US20130260385 Identification and enrichment of cell subpopulations |
| 10/03/2013 | US20130260379 Signaling conjugates and methods of use |
| 10/03/2013 | US20130260371 Apparatus and method for molecular separation, purification, and sensing |
| 10/03/2013 | US20130260370 Microorganism concentration process and device |
| 10/03/2013 | US20130260367 Nmr systems and methods for the rapid detection of analytes |
| 10/03/2013 | US20130260364 Multifunctional Bioreactor system and methods for cell sorting and culturing |
| 10/03/2013 | US20130259883 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis |
| 10/03/2013 | US20130259877 Reagents, methods, and kits for the classification of cancer |
| 10/03/2013 | US20130259869 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| 10/03/2013 | US20130259867 Diagnosis and treatments relating to her3 inhibitors |
| 10/03/2013 | US20130259858 Signature for Predicting Clinical Outcome in Human HER2+ Breast Cancer |
| 10/03/2013 | US20130259829 Clip inhibitors and methods of modulating immune function |
| 10/03/2013 | US20130259808 Multifunctional nanoparticles |